Banamine Injectable Solution is an anti-inflammatory and analgesic.
Used in horses for the alleviation of inflammation and pain associated with musculoskeletal disorders and for te alleviation of visceral pain associated with colic.
Indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Each ml of Baytril 100 injectable solution contains 100 mb enrofloxacin.
Indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Each ml of Baytril 100 injectable solution contains 100 mb enrofloxacin.
Indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Each ml of Baytril 100 injectable solution contains 100 mb enrofloxacin.
For the treatment of disease in dairy cattle, beef cattle and swine. Ready-to-use solution of the broad-spectrum antibiotic oxytetracycline by injection. Delivers rapid sustainable blood levels.
Indicated for the treatment of the following diseases in dairy cattle and beef cattle when due to oxytetracycline-susceptible organisms: pneumonia, shipping fever complex, pinkeye, footrot, diphtheria, lepto, wound infections and acute metritis.
Bo-Se is recommended for the prevention and treatment of white muscle disease syndrome in calves, lambs, and ewes, and as an aid in the prevention and treatment of Selenium-Tocopherol Deficiency in sows and weanling pigs.
CEFENIL RTU is indicated for treatment/control of swine bacterial respiratory disease (swine bacterial pneumonia) associated with Actinobacillus (Haemophilus) pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis and Streptococcus suis. Cattle: CEFENIL RTU is indicated for treatment of the following bacterial diseases: Bovine respiratory disease (BRD, shipping fever, pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. Acute bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus. Acute metritis (0 to 14 days post-partum) associated with bacterial organisms susceptible to ceftiofur. Do not store above 30 deg C (86 deg. F). Protect from freezing. FDA Approved, Zero Milk Discard, Ready-To-Use Formulation, Multi day Treatment Regimen.
CEFENIL RTU is indicated for treatment/control of swine bacterial respiratory disease (swine bacterial pneumonia) associated with Actinobacillus (Haemophilus) pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis and Streptococcus suis. Cattle: CEFENIL RTU is indicated for treatment of the following bacterial diseases: Bovine respiratory disease (BRD, shipping fever, pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. Acute bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus. Acute metritis (0 to 14 days post-partum) associated with bacterial organisms susceptible to ceftiofur. Do not store above 30 deg C (86 deg. F). Protect from freezing. FDA Approved, Zero Milk Discard, Ready-To-Use Formulation, Multiday Treatment Regimen.
For use as an aid in the treatment of hypocalcemia (parturient paresis, milk fever), hypomagnesemia (grass tetany), and other conditions associated with calcium, magnesium, phosphorus, and potassium deficiencies in cattle.
A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.